- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06179550
Intermittent Oro-esophageal Tube Feeding on Cerebral Small Vessel Disease Patients With Dysphagia (CSVD)
A Randomized Controlled Study to Explore the Clinical Effect of Intermittent Oro-esophageal Tube Feeding vs. Nasogastric Tube Feeding on Cerebral Small Vessel Disease Patients With Dysphagia
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Nasogastric tube feeding (NGT) has been widely used in cerebral small vessel disease (CSVD) patients with dysphagia but has a significant risk of complications. Intermittent Oro-esophageal Tube Feeding (IOE) is an established enteral nutrition approach that can be used with comprehensive rehabilitation therapy. This study aims to explore the clinical effect of IOE vs. NGT on CSVD Patients with Dysphagia.
This was a randomized controlled study with 60 CSVD Patients with Dysphagia who received comprehensive rehabilitation therapy. Patients enrolled were randomly divided into the observation group (with IOE, n=30) and the control group (with NGT, n=30). At admission and after treatment, Video Fluoroscopic Swallowing Study (VFSS) and Functional Oral Intake Scale (FOIS), body mass index (BMI), serum albumin (Alb), and hemoglobin (Hb), Modified Barthel Index (MBI) and World Health Organization Quality of Life Assessment Instrument Brief Version (WHOQOL-BREF) were recruited to assess and compare dysphagia, nutritional status, activities of daily living (ADL) and quality of life (QOL). The incidence of pneumonia was recorded and compared.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Henan
-
Zhengzhou, Henan, China, 450000
- Zheng da yi fu yuan hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Clinical diagnosis of CSVD, confirmed by MRI;
- Must be able to cooperate with treatment and questionnaire investigation, (Generally with a Mini-Mental State Examination (MMSE) score ≥ 24) ;
- Clinical diagnosis of dysphagia through the Functional Oral Intake Scale (FOIS) and Video Fluoroscopic Swallowing Study (VFSS);
- Age between 40 and 70 years;
- Enteral nutrition support was required and feasible.
- No history of prior stroke.
Exclusion Criteria:
- Dysphagia related to other cerebrovascular diseases or caused by neurodegenerative diseases;
- Complicated with severe liver and kidney failure, tumors, or hematological disorders;
- Simultaneously need to undergo other therapy that might affect the outcomes of this study;
- Unable or unwilling to undergo VFSS;
- Pregnant or nursing females.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: The control group
Assigned by the random number table. During the treatment, all patients were provided with comprehensive rehabilitation therapy as follows:
Besides, the control group was given enteral nutritional support with NGT according to the relevant guidelines. Within 4 hours after admission, the placement of the feeding tube was conducted by professional medical staffs and after intubation, the tube was secured to the patient's cheek with medical tape. The feeding was conducted once every 3-4 hours, with 200-300ml each time. The total feeding volume was determined based on daily requirements. |
Besides, the control group was given enteral nutritional support with NGT according to the relevant guidelines.
Within 4 hours after admission, the placement of the feeding tube was conducted by professional medical staffs and after intubation, the tube was secured to the patient's cheek with medical tape.
The feeding was conducted once every 3-4 hours, with 200-300ml each time.
The total feeding volume was determined based on daily requirements.
The feeding content was formulated by the nutritionists based on the patient's condition and relevant guidelines to reach the energy demand as 20-25 kcal/kg/day and protein supplementation of 1.2-2.0
g/kg/day for both two groups.
For patients with limited tube feeding compliance, we made appropriate adjustments to ensure that they were not at risk of severe malnutrition as much as possible.
Other Names:
|
|
Experimental: The observation group
Assigned by the random number table.During the treatment, all patients were provided with comprehensive rehabilitation therapy as follows:
The observation group was given enteral nutritional support with IOE according to the following procedure. The feeding content was formulated by the nutritionists based on the patient's condition and relevant guidelines to reach the energy demand as 20-25 kcal/kg/day and protein supplementation of 1.2-2.0 g/kg/day for both two groups |
The observation group was given enteral nutritional support with IOE according to the following procedure: Before each feeding, inside and outside of the tube was cleaned with water.
During feeding, the patient should maintain a semi-reclining or sitting position with mouth opened, and the tube was inserted slowly and smoothly into the upper part of the esophagus by medical staffs while the appropriate depth of intubation was checked with the calibration markings on the tube wall.
The distance from the incisors to the head part of the tube should be between 22-25 cm (Appendix).
However, the specific depth should be evaluated based on patients' feedback and adjusted accordingly.
After insertion, the tail part of the tube should be put into a container full of water and the absence of continuous bubbles indicated a successful intubation.
Then, the feeding was to be conducted three times per day with 50 ml per minute and 400-600ml for each feeding.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Video Fluoroscopic Swallowing Study
Time Frame: day 1 and day 15
|
Video Fluoroscopic Swallowing Study, which is considered as the "gold standard", swallowing process is divided into four periods: cognitive, oral, pharyngeal, and esophageal periods with a total score of 10 and a higher score indicates better swallowing ability (less dysphagia).
|
day 1 and day 15
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional Oral Intake Scale
Time Frame: day 1 and day 15
|
During Dysphagia-Functional Oral Intake Scale assessment, evaluators engage in communication with the patient, conduct observations, and make records to assess the patient's oral intake ability.
The FOIS assessment form includes seven levels of scoring, ranging from level 1 to level 7, indicating a progressive improvement in the patient's oral intake ability.
In general, the result below level 6 indicates unsafe for oral intake while level 6 and above indicates that eating via mouth can be safely conducted.
|
day 1 and day 15
|
|
Body mass index
Time Frame: day 1 and day 15
|
Weight and height will be combined to report Body mass index in kg/m^2
|
day 1 and day 15
|
|
Serum albumin
Time Frame: day 1 and day 15
|
Serum albumin was recorded via blood routine test.(Alb,
g/L)
|
day 1 and day 15
|
|
Hemoglobin
Time Frame: day 1 and day 15
|
Hemoglobin was recorded via blood routine test.(Hb,
mg/L)
|
day 1 and day 15
|
|
Pneumonia
Time Frame: day 1 and day 15
|
The occurrence of pneumonia in patients was assessed before and after treatment.
Specifically, first of all, the symptom assessment and physical examination were conducted to all patients, during which, the doctor would inquire symptoms related to pneumonia, such as cough, sputum production, difficulty breathing, chest pain, etc. and observe the patient's respiratory condition, including respiratory rate, breath sounds, and any abnormal signs in the chest.
If there was probability for potential pneumonia, patients were requested to undergo lung CT for further diagnosis
|
day 1 and day 15
|
|
Activities of daily living
Time Frame: day 1 and day 15
|
The activities of daily living was assessed utilizing the Modified Barthel Index (MBI).
Modified Barthel Index includes the following 10 subscales.
For each subscale, choices encoded with the score 10, 8, 5, 2, 0 are set with the decreasing level of self-dependence, while the final total is positively correlated with Activities of daily living.
Cronbach's α of questionnaire adopted is 0.916.
|
day 1 and day 15
|
|
World Health Organization Quality of Life Assessment Instrument Brief Version
Time Frame: day 1 and day 15
|
The Quality of Life was assessed utilizing the World Health Organization Quality of Life Assessment Instrument Brief Version (WHOQOL-BREF).
WHOQOL-BREF covers various aspects such as mobility, pain, emotions, personal relationships, living conditions, and access to health services, to evaluate Quality of Life.
Each item is rated on a Likert scale, and the scores are transformed into a standardized score ranging from 0 to 100, with higher scores indicating better Quality of Life.
|
day 1 and day 15
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Nieto Luis, Master, Site Coordinator of United Medical Group located in Miami
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022-KY-1532
- Zhengzhou University (Registry Identifier: kfkioecsvd)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebral Small Vessel Diseases
-
Ain Shams UniversityNot yet recruitingCerebral Small Vessel Disease and OCT Angio
-
First Affiliated Hospital of Chengdu Medical CollegeNot yet recruitingCerebral Small Vessel Disease
-
Assistance Publique - Hôpitaux de ParisUnknownSmall Vessel Cerebrovascular DiseaseFrance
-
Johannes DorstRecruitingStroke | Biomarkers | Cerebral Small Vessel Disease | Stroke RecurrenceGermany
-
Zeng ChanghaoRecruitingCerebral Small Vessel DiseasesThailand
-
Shanghai Yueyang Integrated Medicine HospitalRecruitingCerebral Small Vessel DiseasesChina
-
Bin CaiRecruiting
-
Beijing Tiantan HospitalTasly Pharmaceutical Group Co., LtdActive, not recruiting
-
Sunnybrook Health Sciences CentreToronto Rehabilitation InstituteCompleted
-
St. Luke's Hospital, Chesterfield, MissouriWashington University School of MedicineTerminatedCerebral Small Vessel DiseasesUnited States
Clinical Trials on Nasogastric tube
-
Rennes University HospitalCompletedPancreaticoduodenectomy | Digestive System Surgical ProcedureFrance
-
Wakayama Medical UniversityCompleted
-
National Taiwan University HospitalUnknown
-
Yale UniversityWithdrawnSmall Bowel ObstructionUnited States
-
Centre Hospitalier le MansNot yet recruitingIntubated Patient Requiring a Gastric TubeFrance
-
Cancer Institute and Hospital, Chinese Academy...Shanxi Province Cancer Hospital; Guangdong Provincial Hospital of Traditional... and other collaboratorsNot yet recruitingPancreaticoduodenectomy | Minimally Invasive Surgical Procedures | Nasogastric Tube DecompressionChina
-
University of ManitobaCompleted
-
Hamilton Health Sciences CorporationMcMaster UniversityCompleted
-
Heyam Adnan JabbarNot yet recruitingNurse Scope, Practice | Nurse Training | Nurse Based Care Management | Nurse Led InterventionsIraq
-
Federico II UniversityCompleted